The company will work closely with various governments and medical communities to ensure easy availability of ‘Favulous’ to patients across the world.

Investors around the globe, having gold funds in their portfolio, are happy with its rising trend. So, should you bank on DSP World Gold Fund? Let’s find out.

Balrampur Chini Mills Limited has been picked up by our Bollinger Band Squeeze scanner, which suggests that the stock is near a consolidation breakout.

Keep an eye on 11,064 and 11,225 levels as a break on either side would open up for a directional move.  Stocks in news: Alkem Laboratories, Vivimed Labs, Wipro, Bharti Airtel.

Indian markets are expected to the begin the session with modest gains, due to sombre cues from the Asian peers. However, how markets will end today’s session would chiefly depend on the outcome of Reserve Bank of India’s (RBI) policy meet. As the retail inflation is well above the RBI’s comfort zone, street strongly believes that there won’t be any further rate cut.

The consolidated net sales reported in Q1FY21 came in at Rs 53.81 crore, which declined by 40.77 per cent YoY from Rs 90.85 crore in Q1FY20. 

The shares of PI Industries were trading in the green on Wednesday and even rallied to hit an all-time high of Rs 1,966 apiece on BSE after the company reported robust numbers for the first quarter of the financial year 2020-21.

Domestic benchmark indices ended the trading day in the negative territory amid a volatile trading session on Wednesday. Sensex closed down marginally by a mere 24.58 points or 0.07 per cent settling at 37,663.33 while Nifty declined by 24.85 points or 0.22 per cent to close at 11,120.10.

The newly-launched drug, which was the need of the hour, would be available in the form of a strip of ten tablets, marketed under the brand name of Covihalt. It will be used to treat patients having a mild to moderate COVID-19 disease.

Global pharmaceutical major, Zydus Cadila announced on Wednesday that its plasmid DNA vaccine to prevent COVID-19, namely ZyCoV-D, was found to be well-tolerated and safe in phase 1 clinical trial.